Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ayana Pharma

Ayana Pharma
2012 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of liposomal drugs for cancer therapeutics. The company develops generic product based on lipid chemistry that are used for the treatment of ovarian cancer, metastatic breast cancer, AIDS-related Kaposi's sarcoma and multiple myeloma.

Formerly Known As
DoxoCure
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Ein Kerem
  • Jerusalem
  • Israel

Ayana Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ayana Pharma‘s full profile, request access.

Request full access to PitchBook

Ayana Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Ayana Pharma‘s full profile, request access.

Request full access to PitchBook

Ayana Pharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Yossi Bar-On Chief Financial Officer
Yanir Aldouby Chief Operating Officer
Avraham Molcho MD Founder & Chief Executive Officer
Yechezkel Barenholz Co-Founder